about
Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafishFascin 1 is transiently expressed in mouse melanoblasts during development and promotes migration and proliferation.Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivoLoss of nuclear receptor RXRα in epidermal keratinocytes promotes the formation of Cdk4-activated invasive melanomas.Efficient gene expression profiling of laser-microdissected melanoma metastases.Establishment of HRAS(G12V) transgenic medaka as a stable tumor model for in vivo screening of anticancer drugsPregnancy promotes melanoma metastasis through enhanced lymphangiogenesis.Recent advances in sunlight-induced carcinogenesis using the Xiphophorus melanoma modelWnt/β-Catenin Signaling Pathway in Skin Carcinogenesis and Therapy.Melanocytes, melanocyte stem cells, and melanoma stem cells.In vivo screening of S100B inhibitors for melanoma therapy.Modeling Melanoma In Vitro and In Vivo.Lentivirus-mediated bifunctional cell labeling for in vivo melanoma studyCutaneous melanoma: how does ultraviolet light contribute to melanocyte transformation?Studies of Secondary Melanoma on C57BL/6J Mouse Liver Using 1H NMR MetabolomicsRoles of endothelin signaling in melanocyte development and melanoma.Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes.Modelling melanoma in mice.In vitro three-dimensional (3D) models in cancer research: an update.PTEN and melanomagenesis.Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells.Sun exposure, sunbeds and sunscreens and melanoma. What are the controversies?Crosstalk signaling in targeted melanoma therapy.Beta-catenin inhibits melanocyte migration but induces melanoma metastasisEnhancement of DNA repair using topical T4 endonuclease V does not inhibit melanoma formation in Cdk4(R24C/R24C)/Tyr-Nras(Q61K) mice following neonatal UVR.Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas.A histopathological classification system of Tyr::NRASQ61K murine melanocytic lesions: A reproducible simplified classification.A melanocyte--melanoma precursor niche in sweat glands of volar skin.General strategy to analyse coat colour phenotypes in mice.General strategy to analyse melanoma in mice.Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumor.Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.(G12D) NRAS and kinase-dead BRAF cooperate to drive naevogenesis and melanomagenesis.Autochthonous primary and metastatic melanomas in Hgf-Cdk4 R24C mice evade T-cell-mediated immune surveillance.New susceptibility loci for cutaneous melanoma risk and progression revealed using a porcine model.
P2860
Q28476492-32375928-251B-483F-9041-37F6AB7F6501Q30570724-9E0F8583-D438-41ED-9B28-08364455A7A6Q31033276-86688859-9907-487D-8F54-183C34C7F3CCQ34130042-859DC3B5-53E1-4D03-B415-9E26612ADBB8Q34398036-DB598555-25D7-431F-86D6-7FCDF71F78E2Q34559456-66DD3856-A34B-4CAE-AA91-C4CCB54487DEQ34805427-5D75061E-90C4-42F8-9606-3758BBA0D0EDQ35190175-BAAE6A45-D454-425D-954E-E6E6E1B11915Q35674844-40409E47-201F-4B51-8FA1-1BC1F2D7446BQ36640682-AD21CA6C-4BD8-42A3-85D4-76ECB795E54CQ37033010-CAF9FA66-A552-42F5-93E3-355A33793199Q37069214-DA16CC54-4E3A-4E13-A9E8-69659BE91801Q37305457-A7E629D9-4110-40D6-96C0-AE0BEF25D60FQ37352015-803C3ADE-74C3-4AAD-9F50-79CDF1EC92A6Q37608810-66705096-B06D-4E3E-A56D-5359C8D9C5EAQ37686567-DD167C45-B20B-40AF-A332-622884A507A5Q37722851-EB95CFCF-176A-41E1-88E9-BE57D1737C05Q37943839-BB953F40-BDB3-4773-8D41-213C274EE302Q37967634-7DCBFBFD-FED7-43A6-AD99-BCEB65646D83Q38048884-85EDF176-B187-4DF5-BA9A-1F9A702C67C1Q38083887-52D08462-558C-4558-BF55-EB7E55713A26Q38154185-1301E1BD-CD95-48AA-92F1-593355A6F500Q38757522-7329DFF6-8F8D-45D6-B237-A2312213C586Q39337123-9DCB3291-045D-4BA7-83C7-D2D4BA7F88BDQ42460596-02C367B5-455C-48B9-BD04-D882F9DE46B3Q47200013-62A28D79-ADD9-4421-BBCB-D75E2631B255Q48147976-E405335D-8CE9-44BC-8697-BF94E74110CFQ50452224-E954B4A0-F610-4002-8557-A056D8FED90AQ51847405-7573ED1C-124F-4F0D-A991-611AA147DD65Q51852441-85C67038-2E78-4A93-BC13-99B53E7B6234Q51915757-5856E925-9954-44F5-8D43-C3FB75752299Q52628692-CB310327-CF59-4B97-8BE3-0465504F9724Q53233932-D2D27B84-058B-4D98-A29D-B7199C904DAFQ54661171-E7C959A1-F39C-406E-8E5E-C5B3FE3D133EQ55513422-DA9D4B38-509F-41C4-B381-8ED49BB566AD
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cutaneous melanoma in genetically modified animals.
@en
type
label
Cutaneous melanoma in genetically modified animals.
@en
prefLabel
Cutaneous melanoma in genetically modified animals.
@en
P2860
P1476
Cutaneous melanoma in genetically modified animals.
@en
P2093
Friedrich Beermann
Lionel Larue
P2860
P304
P356
10.1111/J.1600-0749.2007.00411.X
P577
2007-12-01T00:00:00Z